Benlysta (Systemic Lupus Erythematosus and Lupus Nephritis)：市場予測と分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 8
1.2 List of Figures 8
2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 9
3 Disease Overview 11
3.1 Etiology and Pathophysiology 11
3.1.1 Etiology 11
3.1.2 Pathophysiology 13
3.2 Prognosis 14
3.3 Quality of Life 14
3.4 Symptoms 15
4 Disease Management 16
4.1 Diagnosis Overview 16
4.1.1 SLE Diagnosis 16
4.1.2 LN Diagnosis 19
4.2 Treatment Overview 21
5 Competitive Assessment 25
5.1 Overview 25
5.2 Strategic Competitor Assessment 26
6 Benlysta (belimumab) 27
6.1 Overview 27
6.2 Efficacy 29
6.3 Safety 32
6.4 SWOT Analysis 33
6.5 Forecast 34
7 Appendix 36
7.1 Bibliography 36
7.2 Abbreviations 38
7.3 Methodology 41
7.4 Forecasting Methodology 41
7.4.1 Diagnosed SLE and LN Patients 41
7.4.2 Percent Drug-Treated Patients 42
7.4.3 General Pricing Assumptions 42
7.4.4 Individual Drug Assumptions 43
7.4.5 Generic Erosion 43
7.5 Physicians and Specialists Included in this Study 44
7.6 Primary Research – Prescriber Survey 46
7.7 About the Authors 47
7.7.1 Analysts 47
7.7.2 Global Head of Healthcare 48
7.8 About GlobalData 49
7.9 Disclaimer 49